EIKEN CHEMICAL CO.,LTD. Logo

EIKEN CHEMICAL CO.,LTD.

Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.

4549 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
台東区台東四丁目19番9号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eiken Chemical Co., Ltd., founded in 1939, is a manufacturer specializing in clinical diagnostics. The company's core business involves the development, manufacturing, and sale of pharmaceuticals, reagents, and medical and scientific equipment. Eiken Chemical is a global leader in Fecal Immunochemical Test (FIT) systems, such as its OC-Sensor series, for the early detection of colorectal cancer. Its portfolio also includes microbiological tests for food poisoning bacteria and environmental inspection, serving the broader healthcare and research markets. The company provides comprehensive solutions from sample collection to result reporting for its diagnostic systems.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 07:32
Prospectus
発行登録書(株券、社債券等)
Japanese 32.0 KB
2025-08-08 09:09
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.0 KB
2025-07-10 08:23
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.4 KB
2025-06-25 03:09
Regulatory News Service
訂正発行登録書
Japanese 10.2 KB
2025-06-25 03:05
Regulatory News Service
臨時報告書
Japanese 32.3 KB
2025-06-25 03:00
Governance Information
内部統制報告書-第87期(2024/04/01-2025/03/31)
Japanese 27.1 KB
2025-06-25 03:00
Registration Form
有価証券報告書-第87期(2024/04/01-2025/03/31)
Japanese 2.0 MB
2025-06-25 03:00
Registration Form
確認書
Japanese 9.1 KB
2025-06-24 09:54
Registration Form
訂正発行登録書
Japanese 10.2 KB
2025-06-24 09:51
Share Issue/Capital Change
臨時報告書
Japanese 39.7 KB
2025-06-10 09:22
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 28.0 KB
2025-05-12 03:18
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 28.2 KB
2025-04-10 05:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.2 KB
2025-03-25 04:52
Registration Form
訂正発行登録書
Japanese 10.3 KB
2025-03-25 04:51
Regulatory News Service
訂正発行登録書
Japanese 10.3 KB

Automate Your Workflow. Get a real-time feed of all EIKEN CHEMICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for EIKEN CHEMICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany FYB
Friulchem Logo
CDMO for animal health, providing vet pharma & supplement solutions for pets and livestock.
Italy FCM
Fuji Pharma Co.,Ltd. Logo
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
Japan 4554
Fuso Pharmaceutical Industries,Ltd. Logo
Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.
Japan 4538
FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.
South Korea 220100
Future Medicine  Co., Ltd. Logo
Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.
South Korea 341170
Develops long-acting injectable therapies for chronic diseases and cancer.
South Korea 456160
Gabather AB Logo
Developing novel GABAA receptor drugs for neuropsychiatric disorders.
Sweden GABA
Galapagos NV Logo
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
Belgium GLPG
Galderma Group AG Logo
A pure-play dermatology company with aesthetics, skincare, and therapeutic solutions.
Switzerland GALD

Talk to a Data Expert

Have a question? We'll get back to you promptly.